Events
These events and webinars are intended for veterinary professionals only.
Ears to Rears and everything in between... Why Otic and Skin Cytology is so Important #24018
Speaker:
Cynthia Bauer, DVM, MS, Dipl. ACVD
This presentation will be a case-based discussion on the importance of skin and otic cytology. The presenter will talk about how to diagnose and manage infections using topical therapy and why having cytology is important to improve positive outcomes.
6:00 PM EST
1 RACE-Approved Credit
RACE# 27059-1119680
Tuesday, April 30, 2024, 18:00 - 19:00
location_on Virtual Meeting
Verdinexor: A Novel Oral Therapy for Canine Lymphoma #24196
Speaker:
James Sturzione, DVM, MBS
This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.
7:00 PM EDT
1 RACE-Approved Credit
RACE# 27059-900255
Tuesday, April 30, 2024, 19:00 - 20:00
location_on Dinner Meeting, Hartford, CT
Verdinexor: A Novel Oral Therapy for Canine Lymphoma #24206
Speaker:
Julie Kluxdal, DVM
This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.
7:30 PM PDT
1 RACE-Approved Credit
RACE# 27059-900255
Wednesday, May 1, 2024, 19:30 - 20:30
location_on Dinner Meeting, San Diego, CA
Zennovation in Sedation: Rethinking What is Possible #24207
Speaker:
Julie Kluxdal, DVM
In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.
7:30 PM PDT
1 RACE-Approved Credit
RACE# 27059-918761
Thursday, May 2, 2024, 19:30 - 20:30
location_on Dinner Meeting, San Diego, CA
Todays PSA: Procedural Sedation and Analgesia for the Vet Tech #24019
Speaker:
Katrina Lafferty, BFA, RLAT, CVT, VTS (Anesthesia/Analgesia)
The reasons to sedate our veterinary patients are many. Sedation allows for less stressful handling, positioning, and diagnostic collection for both the patient and veterinary staff. Radiographs, biopsies, IV catheter placement, and potentially even physical exam, nail trimming, ear cleaning and other maintenance procedures can be achieved with more accuracy and safety, and believe it or not, more quickly with appropriate sedation. No one drug possesses every desired quality (reliable sedation, good analgesia, reversibility, minimal side effects) so it is necessary to have a good understanding of many options and combinations so you can choose the right fit for the right situation. A sedation protocol should consider patient personality, comorbities, procedure, and preferred recovery time. The specific drugs and amounts used will depend on several factors. The anesthetist creating the plan will have to evaluate the temperament of the patient, the type of procedure being performed, and the coexisting conditions or contraindications each patient may have.
8:00 PM EST
1 RACE-Approved Credit
RACE# 27059-1119946
Thursday, May 2, 2024, 20:00 - 21:00
location_on Virtual Meeting
Zennovation in Sedation: Rethinking What is Possible #24150
Speaker:
Elizabeth Mongol-Gunter, VMD
In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.
7:00 PM EDT
1 RACE-Approved Credit
RACE# 27059-918761
Tuesday, May 7, 2024, 19:00 - 20:00
location_on Dinner Meeting, Clifton, VA
Update on Managing Canine Hyperadrenocorticism #24216
Speaker:
Sam Gindville, DVM
Canine Hyperadrenocorticism (Cushing’s Disease) can be a challenging yet rewarding disease to manage. This presentation will review all aspects of Cushing’s: basic pathophysiology, clinical signs, diagnostics, differentiating tests, treatment and monitoring. A series of cases to increase understanding of managing Cushing’s patients will be presented and the final section highlights ways to enhance owner compliance.
07:00 PM CDT
RACE# 27059-869593
1.5 RACE-Approved Credit Hour
Tuesday, May 7, 2024, 19:00 - 20:00
location_on Dinner Meeting, Austin, TX
Zennovation in Sedation: Rethinking What is Possible #24229
Speaker:
Kathy Engler, DVM, DABVP
In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.
7:00 PM CDT
1 RACE-Approved Credit
RACE# 27059-918761
Tuesday, May 7, 2024, 19:00 - 20:00
location_on Dinner Meeting, Ankeny, IA
Zennovation in Sedation: Rethinking What is Possible #24188
Speaker:
Elizabeth Mongol-Gunter, VMD
In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.
7:00 PM EDT
1 RACE-Approved Credit
RACE# 27059-918761
Wednesday, May 8, 2024, 19:00 - 20:00
location_on Dinner Meeting, Arlington, VA
Maximizing Topical Therapy in Companion Animal Practice #24217
Speaker:
Sam Gindville, DVM
With dermatologic conditions making up a large volume of the caseload in companion animal medicine and with antimicrobial resistance on the rise, topical therapies need to play a bigger role in dermatologic therapy. This presentation will discuss why topical therapies are helpful and how cytology helps guide topical product choice. The most common active ingredients in topical products for companion animals will be highlighted including their mechanism of action and suggested use. By having a complete understanding of active ingredients, veterinarians will be better equipped to make a topical product selection. Compliance strategies will be discussed to help ensure that what a veterinarian prescribes actually gets used.With dermatologic conditions making up a large volume of the caseload in companion animal medicine and with antimicrobial resistance on the rise, topical therapies need to play a bigger role in dermatologic therapy. This presentation will discuss why topical therapies are helpful and how cytology helps guide topical product choice. The most common active ingredients in topical products for companion animals will be highlighted including their mechanism of action and suggested use. By having a complete understanding of active ingredients, veterinarians will be better equipped to make a topical product selection. Compliance strategies will be discussed to help ensure that what a veterinarian prescribes actually gets used.
07:00 PM CDT
1 RACE-Approved Credit Hour
Wednesday, May 8, 2024, 19:00 - 20:00
location_on Dinner Meeting, Georgetown, TX
Verdinexor: A Novel Oral Therapy for Canine Lymphoma #24230
Speaker:
Kathy Engler, DVM, DABVP
This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.
7 PM CDT
1 RACE-Approved Credit
RACE# 27059-900255
Wednesday, May 8, 2024, 19:00 - 20:00
location_on Dinner Meeting, Ankeny, IA
Successful Sedation Protocols in Everyday Practice #24020
Speaker:
Zenithson Ng, DVM, DABVP
This program will review commonly used sedation protocols and applications in general practice. The speaker will discuss reducing Fear, Anxiety and Stress in the patients and the veterinary team. He will review common methods of pre visit pharmaceuticals, in hospital sedation and examples of protocols that he has successfully used in practice. Finally he will use real-life case examples of sedation and improving FAS for everyone involved.
8:00 PM EST
1 RACE-Approved Credit
RACE# 27059-111944
Wednesday, May 8, 2024, 20:00 - 21:00
location_on Virtual Meeting
Leveraging Procedural Sedation for Canine Patient #24226
Speaker:
Katie Marcus, DVM
Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.
7:00 PM MDT
1 RACE-Approved Credit
Thursday, May 9, 2024, 19:00 - 20:00
location_on Dinner Meeting, Lone Tree, CO
If You're Not Seeing Canine Lymphoma Cases, They Might Be Seeing You! #24021
Speaker:
Natalie Marks, DVM, CVJ
This presentation will start with a quick review of the prevalence of canine lymphoma and why early diagnosis is critical. The bulk of the lecture will focus on five critical areas the veterinary team can focus on for earlier diagnostics and education to pet parents. This includes at-risk breeds, questions to ask in the history, commonly missed clinical signs, subtle physical exam findings that dictate further diagnostics, and recommended workup options (including the spectrum of care.) The final sections of this presentation will discuss how to utilize resources for efficient and effective communication in your practice.
7:00 PM EST
1 RACE-Approved Credit
RACE# 27059-1174212
Thursday, May 16, 2024, 19:00 - 20:00
location_on Virtual Meeting
Leveraging Procedural Sedation for Canine Patient #24125
Speaker:
Jennifer Kasten, DVM
Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.
7:00 PM EDT
1 RACE-Approved Credit
Tuesday, May 21, 2024, 19:00 - 20:00
location_on Dinner Meeting, Bath, OH
PU, PD, Polyphagia - Oh My! Canine Hypercortisolism #24022
Speaker:
Andrew Bugbee, DVM, DACVIM SAIM
This program will walk through the clinical signs, diagnosis, and treatment of Hypercortisolism (Cushing's). The speaker will use a case-based approach to discuss new monitoring protocols and treatment possibilities.
8:00 PM EST
1 RACE-Approved Credit
RACE# 27059-1122012
Tuesday, May 21, 2024, 22:00 - 23:00
location_on Virtual Meeting
Verdinexor: A Novel Oral Therapy for Canine Lymphoma #24126
Speaker:
Jennifer Kasten, DVM
This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.
7:00 PM EDT
1 RACE-Approved Credit
RACE# 27059-900255
Wednesday, May 22, 2024, 19:00 - 20:00
location_on Dinner Meeting, Twinsburg, OH
Zennovation in Sedation: Rethinking What is Possible #24238
Speaker:
Kathy Engler, DVM, DABVP
In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.
7:00 PM CDT
1 RACE-Approved Credit
RACE# 27059-918761
Wednesday, May 22, 2024, 19:00 - 20:00
location_on Dinner Meeting, Waite Park, MN
Canine Regenerative Therapy- Autologous Blood Products #24075
Speaker:
Timothy Smaha, DVM
The presenter reviews canine regenerative therapy. Focus areas include basic principles of regenerative medicine, FDA regulations, and types of autologous blood products. The types of medical devices necessary for processing autologous blood products including centrifugation, filtration, and incubation are all discussed. Additionally a review of current literature on validation of different autologous products in canines and felines will be discussed. Finally there will be a review of the current literature on the uses of Platelet rich plasma in small animal medicine and an overview of how to perform joint injections for companion animals.
8:00 PM EST
1 RACE-Approved Credit
RACE# 27059-973692
Thursday, May 23, 2024, 20:00 - 21:00
location_on Virtual Meeting
Equine Regenerative Therapy - Autologous Blood Products #24023
Speaker:
Lea Walker, DVM, DACVSMR
The presenter reviews equine regenerative therapy. Focus areas include basic principles of regenerative medicine, FDA regulations, and types of autologous blood products. The types of medical devices necessary for processing autologous blood products including centrifugation, filtration, and incubation are all discussed. Additionally, a meta-analysis of current research with regard to platelet rich plasma (PRP), autologous conditioned serum (ACS), autologous protein solutions (APS), and alpha 2 macroglobulin will be analyzed.
7:00 PM EST
1 RACE-Approved Credit
RACE# 27059-924918
Wednesday, May 29, 2024, 19:00 - 20:00
location_on Virtual Meeting
Canine Regenerative Therapy- Autologous Blood Products #24076
Speaker:
Timothy Smaha, DVM
The presenter reviews canine regenerative therapy. Focus areas include basic principles of regenerative medicine, FDA regulations, and types of autologous blood products. The types of medical devices necessary for processing autologous blood products including centrifugation, filtration, and incubation are all discussed. Additionally a review of current literature on validation of different autologous products in canines and felines will be discussed. Finally there will be a review of the current literature on the uses of Platelet rich plasma in small animal medicine and an overview of how to perform joint injections for companion animals.
3:00 PM EST
1 RACE-Approved Credit
RACE# 27059-973692
Monday, June 3, 2024, 15:00 - 16:00
location_on Virtual Meeting
Canine Regenerative Therapy- Autologous Blood Products #24077
Speaker:
Katie Marcus, DVM
The presenter reviews canine regenerative therapy. Focus areas include basic principles of regenerative medicine, FDA regulations, and types of autologous blood products. The types of medical devices necessary for processing autologous blood products including centrifugation, filtration, and incubation are all discussed. Additionally a review of current literature on validation of different autologous products in canines and felines will be discussed. Finally there will be a review of the current literature on the uses of Platelet rich plasma in small animal medicine and an overview of how to perform joint injections for companion animals.
10:00 PM EST
1 RACE-Approved Credit
RACE# 27059-973692
Wednesday, June 5, 2024, 22:00 - 23:00
location_on Virtual Meeting
Navicular Syndrome and Clinical Application of Bisphosphonates in Equine Practice #24024
Speaker:
Brett Turi, DVM
This presentation breaks down the complex mechanisms of bisphosphonates as a drug class and their use in managing the clinical signs of navicular syndrome in horses. The second half of the presentation explores the clinical features of non-nitrogenous bisphosphonates including their efficacy and safety in real world field applications.
7:00 PM EST
1 RACE-Approved Credit
RACE# 27059-963582
Thursday, June 6, 2024, 19:00 - 20:00
location_on Virtual Meeting
Zennovation in Sedation: Rethinking What is Possible #24232
Speaker:
Gregory Long, DVM
In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.
7:00 PM EDT
1 RACE-Approved Credit
RACE# 27059-918761
Thursday, June 6, 2024, 19:00 - 20:00
location_on Dinner Meeting, Daytona Beach, FL
Zennovation in Sedation: Rethinking What is Possible #24025
Speaker:
Kathy Engler, DVM, DABVP
In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.
12:00 PM EST
1 RACE-Approved Credit
RACE# 27059-918761
Tuesday, June 11, 2024, 12:00 - 13:00
location_on Virtual Meeting
Verdinexor: A Novel Oral Therapy for Canine Lymphoma #24026
Speaker:
Gregory Long, DVM
This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.
7:00 PM EST
1 RACE-Approved Credit
RACE# 27059-900255
Wednesday, June 19, 2024, 19:00 - 20:00
location_on Virtual Meeting
Addison’s Disease Cases and Treatment Review #24027
Speaker:
Cynthia Ward, VMD, PhD, DACVIM SAIM
The presenter will discuss Canine Hypoadrenocorticism with a case based approach. There will be a review of common clinical signs, case examples, and treatment of the disease.
7:00 PM EDT
1 RACE-Approved Credit
Thursday, June 27, 2024, 19:00 - 20:00
location_on Virtual Meeting